12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersConnect Biopharma Hldgs (NASDAQ:CNTB) stock rose 44.1% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $88.0 million. Ampio Pharmaceuticals (AMEX:
XPEV, MDB and IQ Are Among Pre Market Gainers
Over $4M Bet On Diversified Healthcare Trust? Check Out These 4 Stocks Under $5 Insiders Are Aggressively Buying
The Dow Jones closed higher by around 150 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders inte
Insider Buy: Rain Oncology
Kevin C Tang, 10% Owner, on May 30, 2023, executed a purchase for 1,088,273 shares in Rain Oncology (RAIN) for $1,158,764. Following the Form 4 filing with the SEC, Tang has control over a total of 3,
HC Wainwright & Co. Reiterates Neutral on Rain Oncologyto Neutral
HC Wainwright & Co. analyst Mitchell Kapoor reiterates Rain Oncology (NASDAQ:RAIN) from Neutral to Neutral.
12 Health Care Stocks Moving In Thursday's After-Market Session
GainersBluejay Diagnostics (NASDAQ:BJDX) shares increased by 23.6% to $0.28 during Thursday's after-market session. At the close, Bluejay Diagnostics's trading volume reached 750.4K shares. This is 18
Rain Therapeutics (RAIN) Receives a Hold From SVB Securities
Stocks That Hit 52-Week Lows On Tuesday
 During Tuesday's morning session, 137 companies made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Bristol-Myers Squibb (NYSE:BMY) was the biggest company in terms of market c
LifeSci Capital Reaffirms Their Hold Rating on Rain Therapeutics (RAIN)
Express News | Rain Therapeutics Cut to Neutral From Buy by Roth MKM
Rain Oncology Slips on Corporate and Portfolio Restructuring
Roth MKM Downgrades Rain Oncology to Neutral From Buy, Trims Price Target to $1.20 From $2
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: Price: 0.99, Change: -0.11,
Rain Therapeutics Price Target Cut to $2.00/Share From $5.00 by EF Hutton
Rain Therapeutics Price Target Cut to $2.00/Share From $5.00 by EF Hutton
Express News | Rain Therapeutics Is Maintained at Hold by EF Hutton
EF Hutton Maintains Hold on Rain Oncology, Lowers Price Target to $2
EF Hutton analyst Tony Butler maintains Rain Oncology (NASDAQ:RAIN) with a Hold and lowers the price target from $5 to $2.
Rain Oncology to Cut 65% of Jobs in Cost-Cutting Push
By Will Feuer Rain Oncology said it plans to reduce its staff by about 65% in a broad cost-cutting push meant to extend the clinical-stage drug company's cash runway to the end of 2026. The company,
Rain Oncology Provides Company Update And Outlines Strategic Priorities Of Milademetan Clinical Programs; Workforce Reduction Of ~65% Of The Company's Employees; With A Transition Of Chief Medical Officer Responsibilities
– Company plans to suspend enrollment in the ongoing milademetan Phase 2 MANTRA-2 basket trial and terminate plans for its Phase 1/2 MANTRA-4 combination trial –– Evaluation of outcomes from the MANTR
Rain Oncology Provides Company Update and Outlines Strategic Priorities of Milademetan Clinical Programs
– Company plans to suspend enrollment in the ongoing milademetan Phase 2 MANTRA-2 basket trial and terminate plans for its Phase 1/2 MANTRA-4 combination trial – – Evaluation of outcomes from the MANT
Stocks That Hit 52-Week Lows On Thursday
 On Thursday, 221 companies hit new 52-week lows. Interesting Facts About Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was Bristol-Myers Squibb (NYSE:BMY).Biocep
Analyst Expectations for Rain Oncology's Future
Within the last quarter, Rain Oncology (NASDAQ:RAIN) has observed the following analyst ratings: BullishSomewhat BullishIndifferentSomewhat BearishBearishTotal Ratings41300Last 30D003001M Ago100002M A
No matches yet
Operations too frequent. Please try again later.
Please check network settings and try again Refresh Refresh
Loading
History record 
Quotes All >
News All >